ELCARIM SCIENCE PTE. LTD. v ZHANG YONGTAI
Key facts
| Court | High Court (General Division) |
|---|---|
| Decided | |
| Judge | Hri Kumar Nair |
| Charges / claim | Contract, Companies |
| Counsel | Fullerton Law Chambers LLC, Lee & Lee, Ling Yuanrong, Quek Mong Hua, Samuel Ang Rong En, Tan Jin Yong, Tham Wei Chern |
Source: [2023] SGHC 211, High Court (General Division), decided — eLitigation. Updated .
Catchwords
Practice Areas
Judges (1)
Counsel (7)
Case Significance
Elcarim Science Pte Ltd v Zhang Yongtai [2023] SGHC 211 is a reserved judgment of Hri Kumar Nair J in the General Division of the High Court, delivered on 15 August 2023 in Suit No 118 of 2021. The plaintiff, Elcarim Science Pte Ltd, a Singapore company in scientific research and development and security-industry supply whose sole shareholder is Dou Suoke, sued its former director and shareholder Zhang Yongtai, who counterclaimed against Elcarim and Dou Suoke. The dispute arises from the 2015 fallout between partners of a small business, and the catchwords span breach and formation of contract, directors' duties, removal and remuneration, and the transfer of shares and share capital.
[2023] SGHC 211 explained
ELCARIM SCIENCE PTE. LTD. v ZHANG YONGTAI ([2023] SGHC 211) is a Singapore judgment decided by the High Court (General Division) on 15 August 2023. It is categorised under Contract and Companies. Within this corpus it has since been cited by 1 other reported Singapore judgment, a measure of how often later decisions have referred to it. This page summarises what the reported decision covers and links the primary sources — the full judgment, the statutes it cites, and the other cases it engages with — so the decision can be read in context. It is reference information, not legal advice, and it does not state the outcome or any holding beyond what the official judgment records.
What is [2023] SGHC 211 about?
ELCARIM SCIENCE PTE. LTD. v ZHANG YONGTAI ([2023] SGHC 211) is a High Court (General Division) decision from 2023. Its published catchwords are “Contract — Breach”, “Contract — Formation”, “Companies — Shares — Transfer”, and “Companies — Directors — Duties”, which indicate the subject matter the judgment addresses. The full reasoning and orders are in the judgment itself, linked below.
Which legislation does [2023] SGHC 211 consider?
The judgment refers to Central Provident Fund Act (Cap 36), Central Provident Fund Act, Companies Act (Cap 50), and Employment Act (Cap 91), among other provisions. The statutes cited are listed in full on this page, each linking to its primary text.
What earlier Singapore cases does [2023] SGHC 211 cite?
Among the in-corpus authorities it refers to are [2023] SGHC 124. The complete list of cases cited, and of later cases that cite this decision, is shown on this page.
How influential is [2023] SGHC 211?
Within this corpus, [2023] SGHC 211 has been cited by 1 later reported Singapore judgment. That count reflects references from other decisions held in this corpus only and is a conservative lower bound on how often the case has actually been cited.
Summary
Elcarim Science sued its former director and shareholder Zhang Yongtai for breaches of duty following a business fallout, and Zhang counterclaimed over his terminated employment and the transfer of his shares. The High Court allowed Elcarim damages of $86,255 relating to three employees, awarded Zhang $11,000 for wrongful termination and damages to be assessed for the conversion of his 50% shareholding, and dismissed all other claims.
What was Elcarim Science Pte Ltd v Zhang Yongtai [2023] SGHC 211 about?
It was a High Court suit before Hri Kumar Nair J between Elcarim Science Pte Ltd and its former director and shareholder Zhang Yongtai, who counterclaimed against Elcarim and shareholder Dou Suoke, arising from a 2015 business fallout, with reserved judgment delivered on 15 August 2023.
What legal issues did [2023] SGHC 211 raise?
The catchwords covered breach and formation of contract, directors' duties, removal and remuneration, and the transfer of shares and share capital, reflecting the dispute between Elcarim Science Pte Ltd, its former director Zhang Yongtai and sole shareholder Dou Suoke.
Statutes Cited
Cases Cited (10)
Related cases
Other Singapore judgments involving the same parties or counsel.
Referenced in
Statutes interpreted in this judgment
Legal concepts & references
Judgment
Read the full judgment on the official Singapore Courts portal.
Read on eLitigationSource: eLitigation ([2023] SGHC 211)